Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Environment-sensitive fluorescent probes targeting mutant IDH1 for in vivo glioma imaging.

Analytica chimica acta - 1 Aug 2026

Li Wenhua, Song Luning, Lv Wenshuo, Xin Tao, Sun Deqing, Zhao Wei

Abstract excerpt

BACKGROUND: Surgery serves as a cornerstone in glioma treatment, yet achieving complete resection remains a significant challenge due to the infiltrative nature of these tumors. Microscopic residual lesions frequently lead to recurrence, whereas excessive resection risks damaging critical neurological functions. Fluorescent imaging technology enables the real-time visualization and precise delineation of glioma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Cell Line, Tumor
Share to Fluorescent Dyes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mice, Nude

Share to Optical Imaging

Source

Identifiers

PMID: 42191299
DOI: 10.1016/j.aca.2026.345591

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Environment-sensitive fluorescent probes targeting mutant IDH1 for in vivo glioma imaging.PMID 42191299Read ↗

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas.Semantic proximity Read ↗

Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma.Semantic proximity Read ↗

Preparation and Preclinical Evaluation of 18F-Labeled Olutasidenib Derivatives for Non-Invasive Detection of Mutated Isocitrate Dehydrogenase 1 (mIDH1).Semantic proximity Read ↗

Identification and characterization of a novel mutant isocitrate dehydrogenase 1 inhibitor for glioma treatment.Semantic proximity Read ↗

Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours.Semantic proximity Read ↗

Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.Semantic proximity Read ↗

Perovskite nanocrystal probes for intraoperative in vitro pathological detection of IDH1 mutation status in glioma.Semantic proximity Read ↗

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trialsSemantic proximity Read ↗

Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic TargetSemantic proximity Read ↗

A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.Semantic proximity Read ↗

Epigenetic Reprogramming of Autophagy Leads to Uncovering a Novel Therapeutic Target for Mutant IDH1 AstrocytomasSemantic proximity Read ↗

Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.